Literature DB >> 28148694

Myalgia in Patients with Dermatomyositis and Polymyositis Is Attributable to Fasciitis Rather Than Myositis: A Retrospective Study of 32 Patients who Underwent Histopathological Examinations.

Kentaro Noda1,2, Ken Yoshida3,4, Taro Ukichi3,4, Kazuhiro Furuya3,4, Kenichiro Hirai3,4, Isamu Kingetsu3,4, Daitaro Kurosaka3,4.   

Abstract

OBJECTIVE: To determine the association between fasciitis and the clinical variables in patients with dermatomyositis (DM) and polymyositis (PM).
METHODS: We retrospectively reviewed the medical records of 32 patients (24 DM, 8 PM) with newly diagnosed DM and PM and in whom fascia and muscle specimens were histopathologically examined. The relationship between fasciitis and the clinical variables was statistically analyzed. These included age, sex, myalgia, muscle weakness, creatine kinase (CK) and aldolase activities, anti-Jo1 antibody, interstitial lung disease, and malignancy.
RESULTS: Twenty (62.5%) of the 32 patients who underwent the histopathological examination of a fascia specimen had fasciitis, including 18 (75%) of 24 patients with DM and 2 (25%) of 8 patients with PM. The frequency of fasciitis was significantly higher among the patients with DM than among the patients with PM (p < 0.05). Histopathologically, fasciitis in PM was very mild in comparison to that in DM. The frequency of myalgia in patients with fasciitis was significantly higher than that in patients without fasciitis (p < 0.05). However, myalgia was not associated with myositis. There were no significant differences in the patients with and without fasciitis in age, sex, manual muscle test 8 scores, CK or aldolase activities, or the presence of anti-Jo1 antibodies and malignancy.
CONCLUSION: The frequency of fasciitis was significantly higher among patients with DM than among those with PM. Fasciitis, rather than myositis, was associated with myalgia.

Entities:  

Keywords:  DERMATOMYOSITIS; FASCIITIS; MYALGIA; MYOSITIS; POLYMYOSITIS

Mesh:

Year:  2017        PMID: 28148694     DOI: 10.3899/jrheum.160763

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Physical Characteristics of Injection Site Pain After COVID-19 mRNA BNT162b2 Vaccination.

Authors:  Katsuyuki Tomita; Shinichi Okada; Shuji Sugihara; Tomoyuki Ikeuchi; Hirokazu Touge; Junichi Hasegawa; Akira Yamasaki
Journal:  Yonago Acta Med       Date:  2021-11-10       Impact factor: 1.641

2.  A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies.

Authors:  Gianluca Sambataro; Chiara Alfia Ferrara; Carla Spadaro; Sebastiano Emanuele Torrisi; Giovanna Vignigni; Ada Vancheri; Giuseppe Muscato; Nicoletta Del Papa; Michele Colaci; Lorenzo Malatino; Stefano Palmucci; Lorenzo Cavagna; Giovanni Zanframundo; Francesco Ferro; Chiara Baldini; Domenico Sambataro; Carlo Vancheri
Journal:  Diagnostics (Basel)       Date:  2022-05-04

3.  Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab.

Authors:  Matthew Js Parker; Mark E Roberts; Paul C Lorigan; Daniel G du Plessis; Hector Chinoy
Journal:  BMJ Case Rep       Date:  2018-02-08

Review 4.  Fasciae of the musculoskeletal system: normal anatomy and MR patterns of involvement in autoimmune diseases.

Authors:  Thomas Kirchgesner; Xavier Demondion; Maria Stoenoiu; Patrick Durez; Adrien Nzeusseu Toukap; Frédéric Houssiau; Christine Galant; Souad Acid; Frédéric Lecouvet; Jacques Malghem; Bruno Vande Berg
Journal:  Insights Imaging       Date:  2018-08-29

5.  MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis.

Authors:  Taro Ukichi; Ken Yoshida; Satoshi Matsushima; Go Kawakami; Kentaro Noda; Kazuhiro Furuya; Daitaro Kurosaka
Journal:  RMD Open       Date:  2019-03-28

6.  Fasciitis as a disease manifestation in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies: a case report of two cases.

Authors:  Ken Yoshida; Haruyasu Ito; Taro Ukichi; Takayuki Matsushita; Kazuhiro Furuya; Kentro Noda; Yoshinao Muro; Daitaro Kurosaka
Journal:  Rheumatol Adv Pract       Date:  2018-04-25

7.  Generalized severe myalgia and oedema: a case of fasciitis associated with mixed connective tissue disease.

Authors:  Kentaro Noda; Takashi Shimoyama; Haruyasu Ito; Ken Yoshida; Daitaro Kurosaka
Journal:  Rheumatol Adv Pract       Date:  2022-07-27

8.  Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis.

Authors:  Ken Yoshida; Haruyasu Ito; Kazuhiro Furuya; Taro Ukichi; Kentaro Noda; Daitaro Kurosaka
Journal:  Arthritis Res Ther       Date:  2017-12-08       Impact factor: 5.156

9.  Rheumatic manifestations of COVID-19: a systematic review and meta-analysis.

Authors:  Jacopo Ciaffi; Riccardo Meliconi; Piero Ruscitti; Onorina Berardicurti; Roberto Giacomelli; Francesco Ursini
Journal:  BMC Rheumatol       Date:  2020-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.